Merck has decided to discontinue production of a combination antibiotic used in hospitals to target life-threatening ...

Even though studies have linked GLP-1s to development of nonarteritic anterior ischemic neuropathy, the risk is not great enough to warrant stopping the medication, according to a speaker at Academy ...

The FDA announced the approval of the first size-adjustable pulmonary valve replacement designed for children with congenital ...

Communication of needs at home and in clinic to build a manageable work schedule is essential to balancing motherhood and a ...

Researchers developed and validated a new classification system that may standardize reporting of all relevant grades of ...

The FDA has granted 510(k) clearance to allow over-the-counter sale of a needle-free continuous glucose monitor, according to ...

SpyGlass Pharma announced the acquisition of Advanced Vision Science in an effort to boost its IOL manufacturing capacity, ...

Ultraprocessed animal- and plant-based foods were associated with greater risks for developing chronic kidney disease among ...

An investigational amylin receptor agonist combined with tirzepatide induced weight loss of up to 23.3% for adults with type ...

Treating dry eye disease with both Xiidra and Miebo led to significant improvements in signs and symptoms, with most patients still using both drops months later, according to data presented at ...

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ...

In the 20 years since the FDA’s approval of rituximab for rheumatoid arthritis, trials and real-world use of B-cell depleting therapies have resulted in surprising successes and unexpected setbacks in ...